Biotech Startups

Baobab AiBio develops therapeutics through a drug discovery pipeline (including candidates GF-103 and GF-203) using cryo-electron microscopy, protein engineering, and quantum computing. It also offers services such as structure determination, electron tomography, protein engineering, and HPC-based modeling.

1 investor

Baqta develops fermented, nutraceutical-grade powder ingredients produced through controlled fermentation of selected raw materials. The customizable powders serve as dietary supplements, food ingredients, animal nutrition products, and inputs for cosmetics.

1 investor

Barcode Nanotech develops nanoparticle-based delivery vehicles for RNA/DNA therapeutics and vaccines, using proprietary lipids and an in vivo and AI-based screening platform to target specific tissues and cells beyond the liver. Its platform aims at selective indications such as hard-to-treat cancers and metabolic diseases.

1 investor

Barnstorm Foundry is a venture studio focused on building and launching life sciences and biotech companies, drawing on advisors in talent acquisition, commercialization, IP, corporate law, and biosensor technology. It supports ventures translating research such as continuous monitoring and real-time physiological measurement into health products.

1 investor

Barricade Therapeutics is a biotech company focused on oncology drug development, working to advance cancer treatments through evidence-based clinical pharmacology.

1 investor

BASE4 develops a molecular blood analysis that uses transcriptomics, genomics, and AI to measure how organs age and detect early biological alterations across multiple health systems. It offers programs for fertility and women's health, general full-body aging analysis, and pharma/clinical research applications such as tissue-level toxicity detection.

1 investor

baseclick provides click chemistry solutions and nucleic acid research products manufactured in Germany. The company serves scientists and researchers globally with application-driven products for reproducible nucleic acid research.

1 investor

Baseline AI provides AI-powered automation for generating clinical trial documentation and data management artifacts from study protocols, including data collection forms, database schemas, validation rules, statistical code, and data mappings—reducing the manual effort typically required across multiple teams at pharmaceutical companies.

1 investor

Baseline is a biotech company focused on metabolism, obesity, incretins, and GLP-1-based strategies for substance use disorders, drawing on drug development and addiction medicine expertise. It develops therapies and brings drug candidates through clinical and regulatory pathways.

1 investor

baSeq offers an AI agent network that autonomously orchestrates bioinformatics workflows on raw, multi-modal experimental data, executing analysis steps and generating documentation with scientist approval at each critical decision point. It targets life-science and biotech organizations and can be deployed on-prem, in a private cloud, or on baSeq infrastructure.

1 investor

BASi supplies analytical instrumentation and scientific research services to pharmaceutical companies developing new drugs. The company aims to accelerate drug development through improved instrumentation and research capabilities.

1 investor

Baxiva is a biotechnology startup developing glycoconjugate vaccines to prevent bacterial infections with high clinical burden and antimicrobial resistance. Its lead program targets urinary tract and invasive infections caused by Escherichia coli.

1 investor

BayOmics is a proteomics company founded in January 2022 that develops proprietary technologies and tools for protein research to advance disease diagnosis and drug discovery. The company offers research services, reagent kits, instrument platforms, and integrated solutions for applications including tissue microenvironment analysis, biomarker development, and drug target identification.

1 investor

BBI Solutions provides reagents and biochemical products for in vitro diagnostics and life sciences teams, supporting assay development and diagnostic test manufacturing. The company serves IVD manufacturers and life sciences researchers with enzymes, gold colloids, and recombinant reagents.

1 investor

BC Research Inc. is a chemistry-focused contract research and development company offering laboratory, bench-scale, and pilot-scale research services for chemical process innovation. The company serves government, academic, and commercial partners developing novel chemical processes, biobased products, hydrogen separation technologies, and specialized industrial chemistries.

1 investor

BC World Pharm is a pharmaceutical company specializing in bio and chemical sectors that develops and supplies medications while conducting ongoing research and development.

1 investor

BDYHAX was an annual conference in Austin, Texas focused on body hacking and human enhancement, covering topics such as transhumanism, biohacking, bioethics, gene therapy, body modification, and wearable technology. The event featured expert speakers, workshops, vendors, and sponsors across communities including nootropics, prosthetics, implantable tech, and sextech, and is now on indefinite hiatus.

1 investor

Beacon provides a comprehensive drug development database for the life sciences industry, offering detailed intelligence on molecules, therapeutic targets, and companies across various disease areas and modalities. The platform serves biotech and pharmaceutical professionals seeking to analyze therapeutic development pipelines and make informed investment and strategic decisions.

1 investor

Beacon Kits manufactures immunoassay kits for detecting chemical residues and contaminants in food, water, and agricultural samples. The company serves laboratories and testing facilities in food safety, water quality, and agricultural industries.

1 investor

Beactica Therapeutics is a precision medicine company specializing in small molecule drug discovery and development. Founded as a spin-out from Uppsala University, it works with accomplished specialists to develop proprietary therapeutics for pharmaceutical industry needs.

1 investor

BEAM CropTech develops genetic technologies—using cisgenesis and CRISPR/Cas9 gene editing—that optimize plant photobiology to improve crop photosynthesis, yield, drought resistance, and CO2 capture. Its lead technology, PHOTOSYNTER, is licensed as R&D to elite seed genetics companies serving agricultural producers.

1 investor

BeCaps develops a microbial inoculant product combining five beneficial microorganisms to enhance soil health, nitrogen fixation, phosphorus availability, and crop protection for agricultural producers. The formulation is designed as a stable, easy-to-apply solid that integrates with conventional farming practices in Argentina.

1 investor

Beckley Waves is a venture studio focused on the psychedelics field, working on investment strategy, business incubation, partnerships, and new venture development. It also publishes The Trip Report, a newsletter covering psychedelic science, business, and policy.

1 investor

Bedrocan is an EU GMP-certified producer of standardised, pharmaceutical-grade medicinal cannabis used as raw materials and active pharmaceutical ingredients (APIs). It operates its own clinical research unit and supplies healthcare professionals and clinical research with consistent, batch-to-batch cannabinoid formulations.

1 investor